387 results
Showing 1–20 · 0.34 seconds · RSS
Clinical Parkinsonism & Related Disorders
Scopus
ISSN 2590-1125 · Elsevier · 387 articles in the index
-
Journal Article
Efficacy and safety of repetitive transcranial magnetic stimulation on motor function, depression, and cognitive dysfunction in Parkinson’s disease: A systematic review and meta-analysis of randomized controlled trials
Background: Parkinson’s disease (PD) is a multifactorial neurodegenerative disease with a high prevalence worldwide, leading to motor and non-motor symptoms. Moreover, PD presents a progressive aggravation alongside time, the middle and late patients in PD requires the use of a variety of…
-
Journal Article
An unusual case of Pisa syndrome secondary to anti-IgLon 5 disease
Pisa syndrome, characterized by lateral flexion of the trunk, is most often associated with neuroleptic use or neurodegenerative disorders like Parkinson’s disease. Anti-IgLON5 disease is a rare neuroimmunological condition with overlapping features of autoimmunity and tauopathy, manifesting with…
-
Journal Article
Driving impairment in patients with movement disorders: examining the Baylor driving questionnaire by objective driving assessment
Background: The development of a screening tool to identify driving impairment in patients with movement disorders is an unmet need. Objective: To validate Baylor Driving Questionnaire for Movement Disorders (BDQMD) by objective driving assessment (ODA). Methods: In this cross-sectional study, 142…
-
Journal Article
Effects of deep brain stimulation on non motor fluctuations in Parkinson’s disease (assessed with the NMF severity scale)
Background: Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) is a well-established treatment for motor fluctuations (MF) in Parkinson’s disease (PD), but its impact on non-motor fluctuations (NMF) remains unclear. As NMFs are frequent, disabling, and affect quality of life…
-
Journal Article
Polysomnographic characteristics in patients with idiopathic dystonia
Background: Several aspects of the occurrence of sleep disturbances in dystonia remain unclear. Here, we assessed sleep architecture with polysomnography (PSG) and investigated the association of specific findings with mood, quality of life and severity of disease. Methods: Twelve patients with…
-
Journal Article
Treatment-resistant Parkinson's disease psychosis responding to xanomeline-trospium: A case report
We report the case of an 83-year-old male with Parkinsonism and severe psychosis characterized by persistent daytime and nighttime hallucinations associated with marked fear and distress. His psychosis failed to respond to therapeutic trials of quetiapine, brexpiprazole, and pimavanserin. He was…
-
Journal Article
Hospital based motor cognitive rehabilitation training. What after? An intervention aimed at patients' support between admissions
The letter reports on a teleconsultation program for patients with Parkinson's Disease after hospital-based rehabilitation. PwPD and their caregivers were contacted with regular video/phone calls assessing therapy adherence and addressing emerging difficulties. Results showed high satisfaction…
-
Journal Article
Data mining revealed no other trinucleotide repeat expansion associated with the Huntington's disease biomarker (CAG)
The CAG trinucleotide repeat expansion is believed to be the only expansion associated with Huntington's Disease and other phenotypically similar genetic diseases. Here, we mine a large set of data that contains samples from patients of Huntington's disease as well as control to find associated…
-
Journal Article
Comparing daily step counts between a hip and wrist-worn device in adults with Parkinson's disease
Introduction: Wearable devices are increasingly used for measuring physical and physiological activity in daily life. Common appendicular symptoms of Parkinson's disease (PD), such as tremor and rigidity, could impact the accuracy of step counts when the device is worn in different body locations…
-
Journal Article
Access to Parkinson's disease treatments in the Middle East: a multi-national survey of availability, affordability, and utilization patterns
Background: Parkinson's disease (PD) is an increasing public health challenge in the Middle East, yet regional data on access to therapies and services remain limited. Understanding the gaps in PD treatment availability, affordability, and prescription frequency is necessary for improving care…
-
Journal Article
Differentiating effects of levodopa and subthalamic nucleus deep brain stimulation on motor features in Parkinson disease
Introduction: While deep brain stimulation of the subthalamic nucleus (STN DBS) is traditionally used to treat motor fluctuations in Parkinson disease (PD), recent progress in levodopa delivery systems may offer non-invasive alternatives to surgical options. To gain insight into symptoms more…
-
Journal Article
Rotigotine and parkinsonism-hyperpyrexia syndrome
Introduction: Parkinsonism–hyperpyrexia syndrome (PHS) is a potentially fatal complication of Parkinson’s disease (PD) often triggered by antiparkinsonian medication discontinuation or reduction. Rotigotine, a transdermal dopamine agonist, provides continuous drug delivery and can be administered…
-
Journal Article
Sexual dysfunction in movement disorders: prevalence, clinical features, associated factors and management
Sexual dysfunction is a common but insufficiently addressed non-motor symptom in movement disorders. While Parkinson’s disease (PD) is the condition most frequently investigated, sexual dysfunction is also reported in Huntington’s disease, dystonia, and other movement disorders. Clinical…
-
Journal Article
Mark Hallett: scientist and humanitarian in modern movement disorder neurology
Mark Hallett, MD (1943–2025) was a highly influential neurologist in the modern history of movement disorders. Over several decades, his work transformed the field from a predominantly descriptive clinical specialty into a neuroscientific discipline. Through pioneering investigations in…
-
Journal Article
Mark Hallett and the renaissance of functional neurological disorder
This article traces the contributions of Mark Hallett (1943–2025) to Functional Neurological Disorder (FND) from 2003 to his death. Mark brought his expertise in motor physiology, free will, volition and agency to this neglected but common condition. He raised awareness of our need to understand…
-
Journal Article
CSF tap test parameters and Short-Term outcomes in operated and non-operated patients with idiopathic normal pressure Hydrocephalus: A cohort study
Background: Normal Pressure hydrocephalus (NPH) is treated by ventriculoperitoneal shunting. The cerebrospinal fluid tap test (CSF-TT) is widely used to identify candidates for shunt surgery in idiopathic NPH (iNPH). This study aimed to compare the CSF tap test responses and 24-week functional…
-
Journal Article
Temporal patterns of motor and nonmotor symptom emergence in Parkinson’s disease: a cluster analysis
Background: Parkinson’s disease is a heterogeneous disorder characterized by a broad spectrum of motor and nonmotor symptoms. Recent studies suggest that the order of motor and nonmotor symptom development may indicate different subtypes of Parkinson’s disease. However, the temporal occurrence…
-
Journal Article
Epidemiology of Parkinson’s disease – Global burden of disease research from 1990 to 2021 and future trend predictions
Background: Parkinson’s disease (PD), a common neurodegenerative disorder, severely affects patients’ quality of life. This study aims to update the assessment of PD’s prevalence, incidence, mortality, and disability–adjusted life years (DALYs) from 1990 to 2021. Analyses were conducted at…
-
Journal Article
Explore thyself: is it time for metacognition screening in clinical trials?
Participant self-report has become increasingly important in the design of clinical trials for Parkinson’s Disease (PD), resonating with the general sense that a person’s account of their experience should be a prime consideration in evaluating the effects of therapeutics. Typical study designs…
-
Journal Article
Parkinsonism-dystonia syndrome due to a PARK7 gene mutation
We describe a young woman with a novel homozygous PARK7 mutation causing an early-onset and progressive parkinsonism-dystonia syndrome with poor dopaminergic response. Clinical heterogeneity among homozygous mutation carriers emphasises that molecular characterisation of novel variants and detailed…